Logo
x

Search

Subscribe Now

Dry Eye Disease

Kala Pharmaceuticals' Eysuvis (loteprednol etabonate ophthalmic suspension) Receives US FDA's Approval for Dry Eye Disease

Kala Pharmaceuticals' Eysuvis (loteprednol etabonate ophthalmic suspension) Receives US FDA's Approval for Dry Eye Disease

  • October 27, 2020
Image

Incisive News in 3 Shots.

Contact Us

Our Information

Follow Us

Copyright © 2024 PharmaShots - All Rights Reserved.